These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29953201)

  • 21. Small Molecules Detected by Second-Harmonic Generation Modulate the Conformation of Monomeric α-Synuclein and Reduce Its Aggregation in Cells.
    Moree B; Yin G; Lázaro DF; Munari F; Strohäker T; Giller K; Becker S; Outeiro TF; Zweckstetter M; Salafsky J
    J Biol Chem; 2015 Nov; 290(46):27582-93. PubMed ID: 26396193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional properties of Claramine: a novel PTP1B inhibitor and insulin-mimetic compound.
    Qin Z; Pandey NR; Zhou X; Stewart CA; Hari A; Huang H; Stewart AF; Brunel JM; Chen HH
    Biochem Biophys Res Commun; 2015 Feb; 458(1):21-7. PubMed ID: 25623533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.
    Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-Synuclein Proximity Ligation Assay (AS-PLA) in Brain Sections to Probe for Alpha-Synuclein Oligomers.
    Roberts RF; Bengoa-Vergniory N; Alegre-Abarrategui J
    Methods Mol Biol; 2019; 1948():69-76. PubMed ID: 30771171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease.
    Galvagnion C
    J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation.
    George S; Brundin P
    J Parkinsons Dis; 2015; 5(3):413-24. PubMed ID: 26406122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential aggregation properties of alpha-synuclein isoforms.
    Bungeroth M; Appenzeller S; Regulin A; Völker W; Lorenzen I; Grötzinger J; Pendziwiat M; Kuhlenbäumer G
    Neurobiol Aging; 2014 Aug; 35(8):1913-9. PubMed ID: 24629672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.
    Singh SK; Dutta A; Modi G
    Future Med Chem; 2017 Jun; 9(10):1039-1053. PubMed ID: 28632413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polypeptides derived from α-Synuclein binding partners to prevent α-Synuclein fibrils interaction with and take-up by cells.
    Monsellier E; Bendifallah M; Redeker V; Melki R
    PLoS One; 2020; 15(8):e0237328. PubMed ID: 32790707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract.
    Shaltiel-Karyo R; Davidi D; Frenkel-Pinter M; Ovadia M; Segal D; Gazit E
    Biochim Biophys Acta; 2012 Oct; 1820(10):1628-35. PubMed ID: 22575665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of
    Sternke-Hoffmann R; Peduzzo A; Bolakhrif N; Haas R; Buell AK
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcipotriol inhibits α-synuclein aggregation in SH-SY5Y neuroblastoma cells by a Calbindin-D28k-dependent mechanism.
    Rcom-H'cheo-Gauthier AN; Meedeniya AC; Pountney DL
    J Neurochem; 2017 Apr; 141(2):263-274. PubMed ID: 28164279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diphenyl triazine hybrids inhibit α-synuclein fibrillogenesis: Design, synthesis and in vitro efficacy studies.
    Maqbool M; Gadhavi J; Hivare P; Gupta S; Hoda N
    Eur J Med Chem; 2020 Dec; 207():112705. PubMed ID: 32961434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding Caffeine's Role in Attenuating the Toxicity of α-Synuclein Aggregates: Implications for Risk of Parkinson's Disease.
    Kardani J; Roy I
    ACS Chem Neurosci; 2015 Sep; 6(9):1613-25. PubMed ID: 26167732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative.
    Gautam S; Karmakar S; Batra R; Sharma P; Pradhan P; Singh J; Kundu B; Chowdhury PK
    Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):589-603. PubMed ID: 28238838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microwave fields have little effect on α-synuclein aggregation in a Caenorhabditis elegans model of Parkinson's disease.
    de Pomerai DI; Iqbal N; Lafayette I; Nagarajan A; Kaviani Moghadam M; Fineberg A; Reader T; Greedy S; Smartt C; Thomas DW
    Bioelectromagnetics; 2016 Feb; 37(2):116-29. PubMed ID: 26879225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.
    Recasens A; Carballo-Carbajal I; Parent A; Bové J; Gelpi E; Tolosa E; Vila M
    Acta Neuropathol Commun; 2018 Feb; 6(1):8. PubMed ID: 29422109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice.
    Oliveras-Salvá M; Macchi F; Coessens V; Deleersnijder A; Gérard M; Van der Perren A; Van den Haute C; Baekelandt V
    Neurobiol Aging; 2014 Nov; 35(11):2625-2636. PubMed ID: 25037286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclized NDGA modifies dynamic α-synuclein monomers preventing aggregation and toxicity.
    Daniels MJ; Nourse JB; Kim H; Sainati V; Schiavina M; Murrali MG; Pan B; Ferrie JJ; Haney CM; Moons R; Gould NS; Natalello A; Grandori R; Sobott F; Petersson EJ; Rhoades E; Pierattelli R; Felli I; Uversky VN; Caldwell KA; Caldwell GA; Krol ES; Ischiropoulos H
    Sci Rep; 2019 Feb; 9(1):2937. PubMed ID: 30814575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.